Semaglutide, tirzepatide, and retatrutide are among the most effective peptides for weight loss
GIP refers to glucose-dependent insulinotropic polypeptide, another gut hormone involved in insulin release and blood sugar control
Address Structural Barriers to Access: Black Americans and other marginalized communities face systemic barriers to accessing GLP-1 products, including provider bias, geographic disparities, and socioeconomic challenges
Switching between GLP-1 agents Switching from one GLP-1 receptor agonist to another, rather than stopping entirely, is a clinically sound strategy for patients who are changing insurance formularies, experiencing tolerability issues, or seeking a more potent agent
PubMed Coskun, T., Urva, S., Roell, W.C., Qu, H., Loghin, C., Moyers, J.S., OFarrell, L.S., Briere, D.A., Sloop, K.W., Thomas, M.K., Pirro, V., Wainscott, D.B., Willard, F.S., Abernathy, M., Morford, L., Du, Y., Benson, C., Gimeno, R.E., Haupt, A., & Milicevic, Z